Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BANNER CORPBANR · Entity 4398 | Director | November 18, 2016 | November 22, 2016 |
| CLOROX CO /DE/CLX · Entity 3474 | Director | December 31, 2025 | January 05, 2026 |
| LEVI STRAUSS & COLEVI · Entity 3651 | Director | August 08, 2025 | August 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BANNER CORP
Report date November 18, 2016 · Filed November 22, 2016
Jointly reported with FRIEDMAN FLEISCHER & LOWE CAPITAL PARTNERS III LP, FRIEDMAN FLEISCHER & LOWE PARALLEL FUND III LP, FFL Individual Partners III, L.P., FFL EXECUTIVE PARTNERS III LP, Friedman Fleischer & Lowe GP III, L.P., Friedman Fleischer & Lowe GP III, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnotes | 571,800 |
Reported balance
After 2016-11-18 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2016-11-18 · Sale · Disposed 422,693 · Balance 571,800 F2: Held directly by Friedman Fleischer & Lowe Capital Partners III, L.P. F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. |
| Common stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnotes | 378,924 |
Reported balance
After 2016-11-18 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2016-11-18 · Sale · Disposed 280,111 · Balance 378,924 F3: Held directly by Friedman Fleischer & Lowe Parallel Fund III, L.P. F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. |
| Common stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnotes | 12,113 |
Reported balance
After 2016-11-18 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2016-11-18 · Sale · Disposed 8,954 · Balance 12,113 F4: Held directly by FFL Individual Partners III, L.P. F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. |
| Common stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnotes | 11,151 |
Reported balance
After 2016-11-18 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2016-11-18 · Sale · Disposed 8,242 · Balance 11,151 F5: Held directly by FFL Executive Partners, L.P. F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. |
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | Direct | 697 |
Reported balance
Holding disclosure · report date 2016-11-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 697 F1: Represents award of restricted stock pursuant to 2014 Omnibus Incentive Plan; shares fully vest on April 25, 2017. These shares are subject to forfeiture and to limits on transferability until they vest. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents award of restricted stock pursuant to 2014 Omnibus Incentive Plan; shares fully vest on April 25, 2017. These shares are subject to forfeiture and to limits on transferability until they vest.
F2: Held directly by Friedman Fleischer & Lowe Capital Partners III, L.P.
F3: Held directly by Friedman Fleischer & Lowe Parallel Fund III, L.P.
F4: Held directly by FFL Individual Partners III, L.P.
F5: Held directly by FFL Executive Partners, L.P.
F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1.
F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer.
CLOROX CO /DE/
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,018.8638 |
Reported balance
After 2025-11-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-06 · Grant · Acquired 219.3396 · Balance 19,018.8638 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,238.021 |
Reported balance
After 2025-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-31 · Grant · Acquired 1,219.1572 · Balance 20,238.021 F1: 1-for-1 F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,383.2827 |
Reported balance
After 2025-12-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-12-31 · Grant · Acquired 145.2617 · Balance 20,383.2827 F1: 1-for-1 F5: Receipt of Deferred Stock Units in lieu of portion of quarterly director's fees. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
F5: Receipt of Deferred Stock Units in lieu of portion of quarterly director's fees.
LEVI STRAUSS & CO
Report date August 08, 2025 · Filed August 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 64,500 |
Reported balance
After 2025-08-08 transaction · row 1
1 source rowRow 1 · 2025-08-08 · Grant · Acquired 213 · Balance 64,500 F1: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs. |
| Class B Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 116,515 |
Reported balance
After 2025-08-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-08-08 · Grant · Acquired 187 · Balance 116,515 F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs.
F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F3: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2023 Filed Feb 28, 2023 02:55 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013525 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,511 F1 · shares: Represents restricted stock units (RSUs) for Class B common stock constituting dividend equivalent rights (DERs) issued pursuant to existing Class B common stock RSUs held by the holder (the "Underlying Class B RSUs"). DERs are issued with regard to the Underlying Class B RSUs, which bear dividend equivalent rights, when and as dividends were paid on the Issuer's Class B common stock. Each DER represents a contingent right to receive one share of Class B common stock, which is convertible into one share of Class A common stock at the option of the holder. The DERs have all vested. Certain of the Underlying Class B RSUs and the DERs issued pursuant thereto are subject to a deferral delivery feature. Read SEC document |
| February 10, 2023 Filed Apr 4, 2023 20:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 101.4025 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004530 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,035.3826 Underlying: Common Stock · 101.4025 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 22:09 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 219.1263 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000267 · doc4.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,933.9801 Underlying: Common Stock · 219.1263 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F5 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 22:09 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,073.3191 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000267 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,714.8538 Underlying: Common Stock · 1,073.3191 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 21:08 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 280 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058621 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,344 F1 · shares: With respect to 188 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. With respect to 220 of the DERs, the DERs shall vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. With respect to 60 of the DERs, the DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A Common Stock or Class B Common Stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A Common Stock or Class B Common Stock, as appropriate. Read SEC document |
| November 10, 2022 Filed Jan 4, 2023 22:09 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 94.6336 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000267 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,641.5347 Underlying: Common Stock · 94.6336 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:24 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 239.5046 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010692 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,546.9011 Underlying: Common Stock · 239.5046 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 20:24 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046622 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,064 F1 · shares: With respect to 150 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. With respect to 176 of the DERs, the DERs shall vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. With respect to 48 of the DERs, the DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A Common Stock or Class B Common Stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A Common Stock or Class B Common Stock, as appropriate. Read SEC document |
| August 12, 2022 Filed Oct 4, 2022 20:24 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 90.4285 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010692 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,307.3965 Underlying: Common Stock · 90.4285 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 20:55 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 218.116 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008512 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,216.968 Underlying: Common Stock · 218.116 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 24, 2022 Filed May 25, 2022 22:36 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 293 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031972 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,840 F1 · shares: With respect to 148 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. With respect to 213 of the DERs, the DERs shall vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. With respect to 33 of the DERs, the DERs shall vest as to 100% of the shares on the first anniversary of the date of grant. With respect to 47 of the DERs, the DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A Common Stock or Class B Common Stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A Common Stock or Class B Common Stock, as appropriate. Read SEC document |
| May 13, 2022 Filed Jul 5, 2022 20:55 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 80.0218 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008512 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,998.852 Underlying: Common Stock · 80.0218 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| April 20, 2022 Filed Apr 22, 2022 20:07 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025348 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,547 F1 · shares: The shares are represented by restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs will vest in full the earlier of the day before the next Annual Stockholder Meeting or the one-year anniversary of the grant date. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:21 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 221.1753 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005397 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,918.8302 Underlying: Common Stock · 221.1753 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:37 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 181 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013595 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,735 F1 · shares: With respect to 109 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. With respect to 157 of the DERs, the DERs shall vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. With respect to 24 of the DERs for Class A Common Stock, the DERs shall vest as to 100% of the shares on the first anniversary of the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A Common Stock or Class B Common Stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A Common Stock or Class B Common Stock, as appropriate. Read SEC document |
| February 11, 2022 Filed Apr 4, 2022 20:21 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 85.4634 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005397 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,697.6549 Underlying: Common Stock · 85.4634 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 918.6024 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000181 · doc4.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,612.1915 Underlying: Common Stock · 918.6024 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F5 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 176 | $174.36 | $30,687.36 |
DisclosureSEC source: 0001225208-22-000181 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,305 F1 · kind: Receipt of Common Stock in lieu of quarterly director's fee. Read SEC document |
| November 17, 2021 Filed Nov 18, 2021 22:05 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 114 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-065528 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,554 F1 · shares: With respect to 69 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. With respect to 99 of the DERs, the DERs shall vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. With respect to 15 of the DERs for Class A Common Stock, the DERs shall vest as to 100% of the shares on the first anniversary of the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A Common Stock or Class B Common Stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A Common Stock or Class B Common Stock, as appropriate. Read SEC document |
| November 10, 2021 Filed Jan 4, 2022 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 67.4944 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000181 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,693.5892 Underlying: Common Stock · 67.4944 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:45 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 185 | $165.61 | $30,637.85 |
DisclosureSEC source: 0001225208-21-012805 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,129 F1 · kind: Receipt of Common Stock in lieu of quarterly director's fee. Read SEC document |
| August 18, 2021 Filed Sep 2, 2021 21:18 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054507 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,440 F1 · shares: With respect to 70 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. With respect to 113 of the DERs, the DERs shall vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. With respect to 15 of the DERs for Class A Common Stock, the DERs shall vest as to 100% of the shares on the first anniversary of the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A Common Stock or Class B Common Stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A Common Stock or Class B Common Stock, as appropriate. Read SEC document |
| August 13, 2021 Filed Oct 4, 2021 21:45 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 65.835 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-012805 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,626.0948 Underlying: Common Stock · 65.835 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 01:17 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 5,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-047315 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,312 F1 · shares: The shares are represented by restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs will vest in full on July 15, 2022. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 170 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-010104 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 944 F1 · kind: Receipt of Common Stock in lieu of receipt of director's fees pursuant to the Independent Directors' Stock-Based Compensation Plan. Read SEC document |
| May 25, 2021 Filed May 27, 2021 00:18 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 98 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036093 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,857 F1 · shares: With respect to 61 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. The DERs vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A common stock or Class B common stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A common stock or Class B common stock, as appropriate. Read SEC document |
| May 07, 2021 Filed Jul 2, 2021 20:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 57.6357 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-010104 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,560.2598 Underlying: Common Stock · 57.6357 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 20:49 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 159 | $192.88 | $30,667.92 |
DisclosureSEC source: 0001225208-21-006339 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 774 F1 · kind: Receipt of Clorox Stock in lieu of receipt of director's fees pursuant to the Independent Directors' Stock-Based Compensation Plan. Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 02:27 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 76 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016619 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,759 F1 · shares: With respect to 47 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. The DERs vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A common stock or Class B common stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A common stock or Class B common stock, as appropriate. Read SEC document |
| February 12, 2021 Filed Apr 2, 2021 20:49 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 56.3818 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-006339 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,502.6241 Underlying: Common Stock · 56.3818 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 777.268 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000249 · doc4.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,446.2423 Underlying: Common Stock · 777.268 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F5 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 152 | $201.92 | $30,691.84 |
DisclosureSEC source: 0001225208-21-000249 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 615 F1 · kind: Receipt of Clorox Stock in lieu of receipt of director's fees pursuant to the Independent Directors' Stock-Based Compensation Plan. Read SEC document |
| November 20, 2020 Filed Jan 5, 2021 21:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 47.1325 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000249 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,668.9744 Underlying: Common Stock · 47.1325 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:32 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 146.3101 | $210.17 | $30,749.99 |
DisclosureSEC source: 0001225208-20-012084 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463.3101 F1 · kind: Receipt of Common Stock in lieu of quarterly director's fee. Read SEC document |
| August 14, 2020 Filed Oct 2, 2020 21:32 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 42.4665 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012084 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,621.8419 Underlying: Common Stock · 42.4665 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 23:07 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 12,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043083 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,683 F1 · shares: The shares are represented by restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 140 | $219.37 | $30,711.80 |
DisclosureSEC source: 0001225208-20-009488 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317 F1 · kind: Receipt of Common Stock in lieu of quarterly director's fee. Read SEC document |
| May 08, 2020 Filed May 12, 2020 22:52 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 336 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-028642 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,052 F1 · shares: With respect to 307 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. The DERs vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A common stock or Class B common stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A common stock or Class B common stock, as appropriate. Read SEC document |
| May 08, 2020 Filed Jun 1, 2020 20:31 UTC Amendment | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 518 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-033194 · doc4a.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,234 F1 · shares: With respect to 474 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. The DERs vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A common stock or Class B common stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A common stock or Class B common stock, as appropriate. Read SEC document |
| May 08, 2020 Filed Jul 2, 2020 20:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 44.3379 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-009488 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,579.3754 Underlying: Common Stock · 44.3379 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 177 | $173.25 | $30,665.25 |
DisclosureSEC source: 0001225208-20-005930 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177 F1 · kind: Receipt of Clorox Stock in lieu of receipt of director's fees pursuant to the Independent Directors' Stock-Based Compensation Plan. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:46 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-012665 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,716 F1 · shares: With respect to 306 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. The DERs vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A common stock or Class B common stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A common stock or Class B common stock, as appropriate. Read SEC document |
| February 14, 2020 Filed Apr 2, 2020 20:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 54.537 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-005930 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,535.0375 Underlying: Common Stock · 54.537 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 22:02 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 200.2735 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000348 · doc4.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,480.5005 Underlying: Common Stock · 200.2735 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F5 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 22:02 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,013.0902 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000348 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,280.227 Underlying: Common Stock · 1,013.0902 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 15, 2019 Filed Jan 3, 2020 22:02 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 52.6316 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000348 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,267.1367 Underlying: Common Stock · 52.6316 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| October 17, 2019 Filed Jan 8, 2020 21:32 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 724 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-002530 · doc5.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,381 F1 · shares: With respect to 662 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. The DERs vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A common stock or Class B common stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A common stock or Class B common stock, as appropriate. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 197.5374 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-013037 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,214.5051 Underlying: Common Stock · 197.5374 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 16, 2019 Filed Oct 2, 2019 21:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 45.9248 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-013037 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,016.9677 Underlying: Common Stock · 45.9248 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 21:49 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 195.9376 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-009917 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,971.0429 Underlying: Common Stock · 195.9376 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.